Skip to main content
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Published Web Location
http://europepmc.org/articles/PMC3830749?pdf=renderNo data is associated with this publication.
Abstract
Telomerase reverse transcriptase (TERT) promoter mutations were recently shown to drive telomerase activity in various cancer types, including medulloblastoma. However, the clinical and biological implications of TERT mutations in medulloblastoma have not
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.